116
Views
33
CrossRef citations to date
0
Altmetric
Research Article

Chemotherapeutics and Hormesis

&
Pages 305-353 | Published online: 29 Sep 2008

References

  • Abe, K., Sekizawa, T., and Kogure, K. (1986). Biphasic effects of chlorpromazine on cell viability in a neuro- blastoma cell line. Neurosci. Lett., 71:335–339.
  • Abrahem, A., Certad, G., Pan, X-Q., and Georges, E. (2000). Pleiotropic resistance to diverse antimalarials in acti- nomycin D-resistant Plasmodium falciparum. Biochem. Pharmacol., 59:1123–1132.
  • Acton, E., Narayanan, V.L., Risbood, P.A., Shoemaker, R.H., Vistica, D.T., and Boyd, M.R. (1994). Anticancer specificity of some ellipticinium salts against human brain tumors in vitro. J. Med. Chem., 37:2185–2189.
  • Adachi, Y., Arii, S., Funaki, N., Higashitsuji, H., Fujita, S., Furutani, M., Mise, Masahiro, Zhang, W., and Tobe, Takayoshi. (1992). Tumoricidal activity of Kupffer cells augmented by anticancer drugs. Life Sci., 51:177– 183.
  • Adachi, Y., Arii, S., Monden, K., Itai, S., Sasaoki, T., Funaki, N., Higashitsuji, H., Tamura, J., and Tobe, T. (1990). Acta. Hepatologica. Japonica., 31:711.
  • Adami, H.O., Hsieh, C.C., Lambe, M., Trichopoulos, D., Leon, D., Persson, I., Ekbom, A., and Janson, P.O. (1994). Parity, age at first childbirth, and risk of ova- rian cancer. Lancet, 344:1250–1254.
  • Anderson, S.M. and Dimitrievich, E. (1996). Ovulation in- duction for infertility: is it safe or not? S.D.J. Med., 49:419–421.
  • Andres, M.I., Repetto, G., Sanz, P., and Repetto, M. (1999). Biochemical effects of chlorpromazine on mouse neu- roblastoma cells. Vet. Human Toxicol., 41: 273–278.Bakos, E., Evers, R., Sinko, E., Varadi, A., Borst, P., and Sarkadi, B. (2000). Interactions of the human multidrug resistance proteins MRP1 and MRP2 with organic anions. Mol. Pharmacol., 57:760–768.
  • Bartus, R.T. and Uehara, Y. (1979). Physostigmine and re- cent memory: Effects in young and aged nonhuman primates. Science, 206:1085–1087.
  • Bartolomeo, A.C., Morris, H., and Boast, C.A. (1997). Arecoline via miniosmotic pump improves AF64A- impaired radial maze performance in rats: a possible model of alzheimer’s disease. Neurobiol. Learn. Memory, 68:333–342.
  • Basco, L.K. and Le Bras, J. (1994). In vitro susceptibility of Cambodian isolates of Plasmodium falciparum to halofantrine, pyronaridine and artemisinin derivatives. Ann. Trop. Med. Parasitol., 88:137–144.
  • Bentel, J.M., Lebwohl, D.E., Cullen, K.J., Rubin, M.S., Rosen,
  • N., Mendelsohn, J., and Miller, W.H., Jr. (1995). In- sulin-like growth factors modulate the growth inhibi- tory effects of retinoic acid on MCF-7 breast cancer cells. J. Cell. Physiol., 165:212–221.
  • Berger, P.A., Davis, K.L., and Hollister, L.E. (1979). Cholinomimetics in mania, schizophrenia and memory disorders. In: Nutrition and the Brain, Vol. 5. (Barbeau, A., Growdon, J.H., and Wurtman, R.J., Eds.). Raven, New York, pp. 425–441.
  • Blum, A. and Cannon, R.O.I. (1998). Effects of oestrogens and selective oestrogen receptor modulators on serum lipoproteins and vascular function. Curr. Opin. Lipidol., 9:575–586.
  • Boyera, N., Galey, I., and Bernard, B.A. (1997). Biphasic effects of minoxidil on the proliferation and differen- tiation of normal human keratinocytes. Skin Pharmacol., 10:206–220.
  • Braida, D., Paladini, E., Griffini, P. Lamperti, M., Maggi, A., and Sala, M. (1996). An inverted U-shaped curve for heptylphysostigmine on radial maze performance in rats: comparison with other cholinesterase inhibitors. Eur. J. Pharmacol., 302:13–20.
  • Braida, D., Paladini, E., Griffini, P., Lamperti, M., Colibretti, L., and Sala, M. (1998). Long-lasting antiamnesic effect of a novel anticholinesterase inhibitor (MF268). Pharmacol. Biochem. Behav., 59:897–901.
  • Brandon, E.P., Idzerda, R.L., and McKnight, G.S. (1997). PKA isoforms, neural pathways and behaviour: Mak- ing the connection. Curr. Opin. Neurobiol., 7:397– 403.
  • Breen, R.A. and McGaugh, J.L. (1961). Facilitation of maze learning with post trial injections of picrotoxin. J. Comp. Physiol. Psychol., 54:498–501.
  • Bryant, H.U., Holaday, J.W., and Bernton, E.W. (1989). Cysteamine produced dose-related bidirection immunomodulatory effects in mice. J. Pharmacol. Exper. Therap., 249:424–429.
  • Canal, N. and Imbimbo, B.P. (1996). Relationship between pharmacodynamic activity and cognitive effects of eptastigmine in patients with Alzheimer’s disease. Clin. Trials Therap., 60:218–228.
  • Chetrite, G.S., Kloosterboer, H.J., Philippe, J-C., and Pasqualini, J.R. (1999). Effect of Org OD14 (LIVIAL) and its metabolites on human estrogen sulphotransferase ac- tivity in the hormone-dependent MCF-7 and T-47D, and the hormone-independent MDA-MB-231, breast cancer cell lines. Anticancer Res., 19:269–276.
  • Chien, K.R., Pfau, R.G., and Farber, J.L. (1979). Ischemic myocardial cell injury. Am. J. Pathol., 97:505–522.
  • Chu, B.C.F. and Howell, S.B. (1981). Pharmacological and therapeutic properties of carrier bound methotrexate against tumor confined to a third space body compart- ment. J. Pharmacol. Exper. Therap., 219:389–393.
  • Chute, J.P., Kelley, M.J., Venzon, D., Williams, J., Roberts, A., and Johnson, B.E. (1996). Retreatment of patient surviving cancer-free two or more years after initial treatment of small cell lung cancer. Chest, 110:165– 171.
  • Cihlar, T. and Bischofberger, N. (1998). PMEA and PMPA: Acyclic nucleoside phosphonates with potent anti- HIV activity. In: Trends in Drug Research II. (Van der Goot, H., Ed). Elsevier Publishing Co., Amsterdam, pp. 105–116.
  • Cole, S.P.C., Bhardwaj, G., Gerlach, J.H., Mackie, J.E., Grant, C.E., Almquist, K.C., Stewart, A.J., Kurz, E.U., Duncan, A.M.V., and Deeley, R.G. (1992). Overexpression of a transporter gene in a multidrug-resistant human lung cancer line. Science (Wash. DC), 258:1650–1654.
  • Cowman, A.F., Galatis, D., and Thompson, J.K. (1994). Selection for mefloquine resistance in Plasmodium falciparum is linked to amplification of the pfmdrl gene and cross-resistance to halofantrine and quinine. Proc. Natl. Acad. Sci. USA, 91:1143–1147.
  • Crook, D. and Seed, M. (1990). Endocrine control of plasma lipoprotein metabolism: effects of gonadal steroids. In: Bailliere’s Clinical Endocrinology and Metabolism, (Betteridge, D.J., Ed.). Bailliere Tindall, pp. 851–875.
  • Cui, Y., Buchholz, J.K., Spring, H., Leier, I., and Keppler, D. (1999). Drug resistance and ARP dependent conju- gate transport mediated by the apical mutlidrug resis- tance protein, MRP2, permanently expressed in hu- man and canine cells. Mol. Pharmacol., 55:929–937.
  • Cundy, K.C., Barditch-Crovo, P., Walker, R.E., Collier, A.C., Ebeling, D., Toole, J., and Jaffe, H.S. (1995). Clinical pharmacokinetics of adefovir in human immunodefi- ciency virus type 1–infected patients. Antimicrob. Agents Chemother., 39:2401–2405.
  • Currens, M.J., Gulakowski, R.J., Mariner, J.M., Moran, R.A., Buckheit, Jr., R.W., Gustafson, K.R., McMahon, J.B., and Boyd, M.R. (1996). Antiviral activity and mecha- nism of action of calanolide A against the human immunodeficiency virus type-1. JPET, 279:645–651.
  • Davis, K.L. (1981). Multiple dose intravenous physostig- mine in Alzheimer’s disease. International Study Group on the Pharmacology of Memory Disorders Associ- ated with Aging, Zurich, April.
  • De Clercq, E., Billiau, A., Ottenheijm, H.C.J., and Herscheid, J.D.M. (1978). Antireverse transcriptase activity of gliotoxin analogs. Biochem. Pharmacol., 27:635–639.
  • Deliconstantinos, G., Kipeikina-Tsiboukidou, L., and Villiotou, V. (1987). Evaluation of membrane fluidity effects and enzyme activities alterations in adriamycin neurotoxicity. Biochem. Pharmacol., 36:1153–1161.
  • Della Fazia, M.A., Servillo, G., and Sassone-Corsi, P. (1997). Cyclic AMP signalling and cellular proliferation: Regulation of CREB and CREM. FEBS Lett., 410:22– 24.
  • Doull, J. (2001). Toxicology comes of age. Annu. Rev. Pharmacol. Toxicol., 41:1–21.
  • Egorin, M.J., Clawson, R.E., Cohen, J.L., Ross, L.A., and Bachur, N.R. (1979). Cellular pharmacology of 7(R)- O-methylnogarol: a new anticancer agent. J. Pharmacol. Exp. Therap., 210:229–236.
  • ElAttar, T.M. and Virji, A.S. (1999). Modulating effect of resveratrol and quercetin on oral cancer cell growth and proliferation. Anti-Cancer Drugs, 10:187–193.
  • ElAttar, T.M., and Virji, A.S. (2000). Effect of tea polyphe- nols on growth of oral squamous cells in vitro. Anti- cancer Res., 20:3459–3465.
  • Fanin, R., Banerjee, D., Volkenandt, M., Waltham, M., Li, W.W., Dicker, A.P., Schweitzer, B.I., and Bertino, J.R. (1993). Mutations leading to antifolate resistance in Chinese hamster ovary cells after exposure to the alkylating agent ethylmethanesulfonate. Mol. Pharmacol., 44:13–21.
  • Farber, J.L., Chien, K.R., and Mittnacht, S. (1981). The pathogenesis of irreversible cell injury in ischemia. Am. J. Pathol., 102:271–281.
  • Ferreri, L.F. and Naito, H.K. (1978). Effect of estrogens on rat serum cholesterol concentration: consideration of dose, type of estrogen, and treatment duration. Endo- crinology, 102:1621–1627.
  • Fischer, P.H. and Baxter, D. (1982). Enzyme regulatory site- directed drugs: Modulation of thymidine triphosphate inhibition of thymidine kinase by 5’-amino-5’- deoxythymidine. Mol. Pharmacol., 22:231–234.
  • Flood, J.F., Landry, D.W., and Jarvik, M.E. (1981). Cholin- ergic receptor interactions and their effects on long- term memory processing. Brain Res., 215:177–185.
  • Foekens, J.A., Sieuwerts, A.M., Stuurman-Smeets, E.M.J., Dorssers, L.C.J., Berns, E.M.J.J., and Klijn, J.G.M. (1992). Pleiotropic actions of suramin on the prolif- eration of human breast cancer cells in vitro. Int. J. Cancer, 51:429–444.
  • Frenkel, G.D. and Falvey, D. (1988). Evidence for the in- volvement of sulfhydryl compounds in the inhibition of cellular DNA synthesis by selenite. Mol. Pharmacol., 34:573–577.
  • Gale, G.R. (1965). Effect of 2,3–bis-(2–chloroethyl)-1– nitrosourea on Ehrlich ascites tumor cells. Biochem. Pharmacol., 14:1705–1710.
  • Giacobini, E. (1991). The second generation of cholinest- erase inhibitors: Pharmacological aspects. In: Cholin- ergic Basis for Alzheimer Therapy. (Becker, R.E. and Giacobini, E., Eds.). Birkhauser, Boston, MA, p. 1.
  • Giacobini, E. and Cuadra, G. (1994). Second and third gen- eration cholinesterase inhibitors: From preclinical stud- ies to clinical efficacy. In: Alzheimer Disease: Thera- peutic Strategies (Giacobini, E. and Becker, R.E., Eds.). Birkhauser, Boston, MA, p. 1.
  • Go, V., Garey, J., Wolff, M.S., and Pogo, B.G.T. (1999). Estrogenic potential of certain pyrethroid compounds in the MCF-7 human breast carcinoma cell line. Environ. Health Perspect., 107:173–177.
  • Goldin, A., Venditti, J.M., Mead, J.A.R., and Glynn, J.P. (1964). Cancer Chemother. Rep., 40:57.
  • Goormaghtigh, E. and Ruysschaert, J.M. (1984). Anthracycline glycoside-membrane interactions. Biochim. Biophys. Acta, 779:271–288.
  • Goren, M.P., Wright, R.K., Pratt, C.B., and Pell, F.E. (1986). Dechloroethylation of ifosfamide and neurotoxicity. Lancet, 2:1219–1220.
  • Haroutunian, V., Barnes, E., and Davis, K.L. (1985). Cholin- ergic modulation of memory in rats. Psychopharma- cology, 87:266–271.
  • Henry, J.A. and Cassidy, S.L. (1986). Membrane stabilizing activity: a major cause of fatal poisoning. Lancet, 1414–1417.
  • Hidalgo, E. and Dominguez, C. (2000). Growth-altering ef- fects of sodium hypochlorite in cultured human der- mal fibroblasts. Life Sci., 67:1331–1344.
  • Houghton, P.J., Bailey, F.C., Germain, G.S., Grindey, G.B., Howbert, J.J., and Houghton, J.A. (1990a). Studies on the cellular pharmacology of N-(4–methylphenylsulfonyl)-N’- (4–chlorophenyl) urea. Biochem. Pharmacol., 39:1187– 1192.
  • Houghton, P.J., Bailey, F.C., Houghton, J.A., Murti, K.G., Howbert, J.J., and Grindey, G.B. (1990b). Evidence for mitochondrial localization of N-(4–methylphenylsulfonyl)- N’-(4–chlorophenyl) urea in human colon adenocarcinoma cells. Cancer Res., 50:664–668.
  • Houslay, M.D. and Milligan, G. (1997). Tailoring cAMP- signaling responses through isoform multiplicity. Trends Biol. Sci., 22:217–224.
  • Ikezaki, K. and Black, K.L. (1990). Stimulation of cell growth and DNA synthesis by peripheral benzodiazepine. Cancer Lett., 49:115–120.
  • Imbimbo, B.P., and Lucchelli, P.E. (1994). A pharmacody- namic strategy to optimize the clinical response to eptastigmine (MF-201). In: Alzheimer Disease: Thera- peutic Strategies. (Giacobini, E. and Becker, R.E., Eds.). Birkhauser, Boston, MA, p. 103.
  • Injeyan, H.S., Meerovitch, E., and McLaughlin, J. (1974). Anomalous enhancing effect of hydroxyurea on DNA synthesis. Life Sci., 14:1687–1693.
  • Kahn, J., Lagakos, S., Wulfsohn, M., Cherng, D., Miller, M.D., Cherrington, J.M., Hardy, D., Beall, G., Cooper, R., Murphy, R., Basgoz, N., Ng, E., Deeks, S., Winslow, D., Toole, J.J., and Coakley, D. (1999). Efficacy and safety of adefovir dipivoxil with antiretroviral therapy: a randomized controlled trial. J. Am. Med. Assoc., 282:2305–2312.
  • Kanda, T., Bunnag, D., Deesin, V., Deesin, T., Leemingsawat, S., Komalamistra, N., Thimasarn, K., and Sucharit, S. (1995). Integration of control measures for malaria vectors in endemic areas of Thailand. Southeast Asian J. Trop. Med. Public Health, 26:154–163.
  • Kelemen, K. and Bovet, D. (1961). Effect of drugs upon the defensive behavior of rats. Acta. Physciol. Acad. Sci. Hung., 19:143–154.
  • Kenney, S., Vistica, D.T., Linden, H., and Boyd, M.R. (1995). Uptake and cytotoxicity of 9–methoxy-N2– methylellipticinium acetate in human brain and non- brain tumor cell lines. Biochem. Pharmacol., 49:23–32.
  • Kim, H.J. and Kalkoff, R.K. (1978). Altered apolipoproteins in sex steroid-treated rats. Metabolism, 27: 571–587.Knopp, R.H. and Zhu, X. (1997). Multiple beneficial effects of estrogen on lipoprotein metabolism (editorial). J. Clin. Endocrinol. Metab., 82:3952–3954.
  • Konishi, I., Kuroda, H., and Mandai, M. (1999). Review: Gonadotropins and development of ovarian cancer. Oncology (Basel), 57(Suppl. 2):45–58.
  • Krishnan, A.V., Stathis, P., Permuth, S.F., Tokes, L., and Feldman, D. (1993). Bisphenol-A: An estrogenic sub- stance is released from polycarbonate flasks during autoclaving. Endocrinology, 132:2279–2286.
  • Lee, J-B., Hayashi, K., Hayashi, T., Sankawa, V., and Maeda, M. (1999). Antiviral activities against HSV-1, HCMV, and HIV-1 of rhamnan sulfate from Monostroma latissimum. Planta Med., 65:439–441.
  • Lind, M.J., McGown, A.T., Hadfield, J.A., Thatcher, N., Crowther, D., and Fox, B.W. (1989). The effect of ifosfamide and its metabolites on intracellular glu- tathione levels in vitro and in vivo. <i>Biochem. Pharmacol., 38:1835–1840.
  • Lippert, C., Seeger, H., Mueck, A.O., and Lippert, T.H. (2000). The effects of A-ring and D-ring metabolites of estradiol on the proliferation of vascular endothe- lial cells. Life Sci., 67:1653–1658.
  • Lippman, M., Bolan, G., and Huff, K. (1976). The effects of estrogens and antiestrogens on hormone-responsive human breast cancer in long-term tissue culture. Can- cer Res., 36:4595–4601.
  • Love-Schimenti, C.D., Gibson, D.F.C., Ratnam, A.V., and Bikle, D.D. (1996). Antiestrogen potentiation of antiproliferative effects of vitamin D3 analogues in breast cancer cells. Cancer. Res., 56:2789–2794.
  • MacIndoe, J.H. and Etre, L.A. (1980). Androgens inhibit estrogen action in MCF-7 human breast cancer cells. Life Sci., 27:1643–1648.
  • McGaugh, J.L. (1961). Facilitative and disruptive effects of strych- nine sulphate on maze learning. Psychol. Rep., 8:99–104.
  • McGaugh, J.L. and Petrinovich, L. (1959). The effect of strychnine sulphate on maze learning. Am. J. Psychol., 72:99–102.
  • McGaugh, J.L., Jennings, R.D., and Thomson, C.W. (1962). The effect of distribution of practice on the maze learning of descendants of the Tryon maze bright and maze dull strains. Psychol. Rep., 9:147–150.
  • Mead, C. and Pentreath, V.W. (1998). Evaluation of toxicity indicators in rat primary astrocytes, C6 glioma and human 1321N1 astrocytoma cells: can gliotoxicity be distinguished from cytotoxicity? Arch. Toxicol., 72:372–380.
  • Merker, P.C., Lewis, L.R., Walker, M.D., and Richardson, E.P., Jr. (1978). Neurotoxicity of adriamycin (doxoru- bicin) perfused through the cerebrospinal fluid space of the rhesus monkey. Tox. Appl. Pharmacol., 44:191– 205.
  • Miodini, P., Fioravanti, L., Fronzo, G.D., and Cappelletti, V. (1999). The two phyto-oestrogens genistein and quer- cetin exert different effects on oestrogen receptor func- tion. Br. J. Cancer, 80:1150–1155.
  • Mishell, T.I. and Dutton, R.W. (1967). Immunization of dissociated spleen cell cultures from normal mice. J. Exp. Med., 126:423–442.
  • Mitchell, J.R., Thorgeirsson, S.S., Potter, W.Z., Jollow, D.J., and Keiser, H. (1974). Acetaminophen-induced he- patic injury: protective role of glutathione in man and rationale for therapy. Clin. Pharmacol. Therap., 16:676–684.
  • Mulato, A.S., Ho, E.S., and Cihlar, T. (2000). Nonsteroidal anti-inflammatory drugs efficiently reduce the trans- port and cytotoxicity of adefovir mediated by the human renal organic anion transporter 1. J. Pharmacol. Exper. Therap., 295:10–15.
  • Murray, R.W., Melchior, E.P., Hagadorn, J.C., and Marotti, K.R. (2001). Staphylococcus aureus cell extract tran- scription-translation assay: firefly luciferase reporter system for evaluating protein translation inhibitors. Antimicro. Agents Chemother., 45:1900–1904.
  • Nagaraj, G., Uma, M.V., Shivayogi, M.S., and Balaram, H. (2001). Antimalarial activities of peptide antibiotics isolated from fungi. Antimicro. Agents Chemother., 45:145–149.
  • Narayan, S., Rajakumar, G., Prouix, H., and Singh, P. (1992). Estradiol is trophic for colon cancer in mice: effect on ornithine decarboxylase and c-myc messenger RNA. Gastroenterology, 103:1823–1832.
  • Nathan, L. and Chaudhuri, G. (1997). Estrogens and athero- sclerosis. Annu. Rev. Pharmacol. Toxicol., 37:477– 515.
  • Nielson, C.P., Brenner, D., and Olson, R.D. (1986). Doxoru- bicin and doxorubicinol-induced alterations in human polymorphonuclear leukocyte oxygen metabolite gen- eration. J. Pharmacol. Exper. Therap., 238:19–25.
  • Ogata, N. and Narahashi, T. (1990). Potent blocking action of chlorpromazine on two types of calcium channels in cultured neuroblastoma cells. J. Pharmacol. Exper. Therap., 252:1142–1149.
  • Pagano, G., de Biase, A., Deeva, I.B., Degan, P., Doronin, Y.K., Iaccarino, M., Oral, R., Trieff, N.M., Warnau, M., and Korkina, L.G. (2001). The role of oxidative stress in developmental and reproductive toxicity of tamoxifen. Life Sci., 68:1735–1749.
  • Parini, P., Angelin, B., Stavreus-Evers, A., Freyschuss, B., Eriksson, H., and Rudling, M. (2000). Biphasic ef- fects of the natural estrogen 17β-estradiol on hepatic cholesterol metabolism in intact female rats. Arterioscler. Throm. Basc. Biol., 20:1817–1823.
  • Pentreath, V.W. and Slamon, N.D. (2000). Astrocyte pheno- type and prevention against oxidative damage in neu- rotoxicity. Hum. Exp. Toxicol., 19:641–649.
  • Peters, B.H. and Levin, H.S. (1977). Memory enhancement after physostigmine treatment in the amnesic syn- drome. Arch. Neurol., 34:215–219.
  • Petrinovich, L. (1963). Facilitation of successive discrimination learning with strychnine sulphate. Psychopharmacologia, 4:103–113.
  • Platt, E.E. (1951). The effects of subcutaneous injections of diisopropyl fluorophosphate (DFP) on the rate of learn- ing a discrimination problem by albino rats. Unpub- lished Ph.D. Dissert., Ohio State Univ. Prescott, L.F., Swainson, C.P., Forrest, A.R.W., Newton, R.W., Wright, N., and Matthew, H. (1974). Success- ful treatment of severe paracetamol overdosage with cysteamine. Lancet, 1:588–591.
  • Prevost, G., Foehrle, E., Thomas, F., Pihan, I., Veber, N., Starzec, A., and Israel, L. (1991). Growth of human breast cancer cell lines is inhibited by the somatostatin analog BIM23014. Endocrinology, 129:323–329.
  • Rall, D.P., Ben, M., and McCarthy, D.M. (1963). Proc. Am. Assoc. Cancer Res., 4:55.
  • Repetto, G. and Sanz, P. (1993). Neutral red uptake, cellular growth and lysosomal function: In vitro effects of 24 metals. ATLA, 21:501–507.
  • Rhee, M.S., Galivan, J., Wright, J.E., and Rosowsky, A. (1994). Biochemical studies on PT523, a potent nonpolyglutamatable antifolate, in cultured cells. Mol. Pharmacol., 45:783–791.
  • Riman, T., Persson, I., and Nilsson, S. (1998). Hormonal aspects of epithelial ovarian cancer: Review of epide- miological evidence. Clin. Endocrinol., 49: 695–707.Rodriguez, C., Patel, A.V., Calle, E.E., Jacob, E.J., and Thun, M.J. (2001). Estrogen replacement therapy and ovarian cancer mortality in a large prospective study of US women. JAMA, 285:1460–1465.
  • Roman, I.D. and Coleman, R. (1994). Disruption of canalicu- lar function in isolated rat hepatocyte couplets caused by cyclosproin A. Biochem. Pharmacol., 48:2181–2188.
  • Ross, G.T., Vande Viele, R.L., and Frantz, A.G. (1981). The ovaries and the breasts. In: Textbook of Endocrinol- ogy, 6th edition. (Williams, R.H., Ed). W.B. Saunders Company, Philadelphia, pp. 355–411.
  • Ruff, M.R., Pert, C.B., Weber, R.J., Wahl, L.M., Wahl, S.M., and Paul, S.M. (1985). Benzodiazepine recep- tor-mediated chemotaxis of human monocytes. Sci- ence, 229:1281–1283.
  • Rush, G.F., Rinzel, S., Boder, G-B., Heim, R.A., Toth, J.E., and Ponster, G.D. (1992). Effects of diarylsulfonylurea antitumor agents on the function of mitochondria iso- lated from rat liver and GC3/cl cells. Biochem. Pharmacol., 44:2387–2394.
  • Sacks, F.M. and Walsh, B.W. (1994). Sex hormones and lipoprotein metabolism. Endocrinology, 60:22–26.
  • Sasaoki, T., Arii, S., Monden, K., Itai, S., and Tobe, T. (1989). Medical, Biochemical and Chemical Aspects of Free Radicals. (Hayaisi, O., Niki, E., Kondo, M., and Yoshikawa, T., Eds.). Elsevier, Amsterdam, pp. 1363–1366.
  • Sasaoki, T., Arii, S., Monden, K., Itai, S., Adachi, Y., Fuanki, N., Higashitsuji, H., Tamura, J., and Tobe, T. (1991). Cells of the Hepatic Sinusoid. (Wisse, E., Knook, D.L., and McCuskey, R.S., Eds). Kupffer Cell Foun- dation, Leiden, pp. 352–353.
  • Schabel, Jr., F.M., Johnston, T.P., McCaleb, G.S., Montgomery, J.A., Laster, W.R., and Skipper, H.E. (1963). Cancer Res., 23:725.
  • Shafer, S.H., Phelps, S.H., and Williams, C.L. (1998). Reduced DNA synthesis and cell viability in small cell lung car- cinoma by treatment with cyclic AMP phosphodiesterase inhibitors. Biochem. Pharmacol., 56:1229–1236.
  • Shu, L.L. and Houghton, P.J. (1996). Separation of resis- tance to antitumor diarylsulfonylurea agents from collateral sensitivity to mitochondrial toxins. Mol. Pharmacol., 49:595–601.
  • Sitaram, N., Weingartner, H., and Gillin, J.C. (1978). Human serial learning enhancement with arecoline and cho- line impairment with scopolamine. Science, 201:274– 276.
  • Soncrant, T.T., Raffaele, K.C., Asthana, S., Berardi, A., Morris, P.P., and Haxby, J.V. (1993). Memory im- provement without toxicity during chronic, low dose intravenous arecoline in Alzheimer’s disease. Psy- chopharmacology, 112:421–427.
  • Sosinski, J., Thakar, J.H., Germain, G.S., Dias, P., Harwood, F.C., Kuttesch, J.F., and Houghton, P.J. (1994). Cross- resistance to antitumor diarylsulfonylureas and collat- eral sensitivity to mitochondrial toxins in a human cell line selected for resistance to the antitumor agent N- (-indanylsulfonyl)-N’-(4–chlorophenyl) urea. Mol. Pharmacol., 45:962–970.
  • Stoica, A., Pentecost, E., and Martin, M.B. (2000). Effects of arsenite on estrogen receptor- expression and activ- ity in MCF-7 breast cancer cells. Endocrinology, 141:3595–3602.
  • Syed, V., Ulinski, G., Mok, S.C., Yiu, G.K., and Ho, S-M. (2001). Expression of gonadotropin receptor and growth responses to key reproductive hormones in normal and malignant human ovarian surface epithe- lial cells. Cancer Res., 61:6768–6776.
  • Tavani, A. and La Vecchia, C. (1999). The adverse effects of hormone replacement therapy. Drugs Aging, 14: 347–357.Thakar, J.H., Chapin, C., Berg, R.H., Ashmun, R.A., and Houghton, P.J. (1991). Effect of antitumor diarylsulfonylureas on in vivo and in vitro mitochondrial structure and functions. Cancer Res., 51:6286–6291.
  • Thal, L.J., Fuld, P.A., Masur, D.M., and Sharpless, N.S. (1983). Oral physostigmine and lecithin improve memory in Alzheimer disease. Ann. Neurol., 113:491– 496.
  • Thoene, J.G., Oshima, R., Crawhall, J., Olson, D., and Schneider, J. (1976). Cystinosis: Intracellular cystine depletion by aminothiols in vitro and in vivo. J. Clin. Invest., 58:180–189.
  • Tiemann, U., Pohland, R., and Schneider, F. (1996a). Influ- ence of organochlorine pesticides on physiological potency of cultured granulosa cells from bovine preo- vulatory follicles. Theriogenology, 46:253–265.
  • Tiemann, U., Schneider, F., and Tuchscherer, A. (1996b). Effects of organochlorine pesticides on DNA synthe- sis of cultured oviductal and uterine cells and on estrogen receptor of uterine tissue from heifers. Arch. Toxicol., 70:490–496.
  • Tutton, P.J.M. and Barkla, D.H. (1982). Differential effects of oestrogenic hormones on cell proliferation in the colonic crypt epithelium and in colonic carcinomata of rats. Anticancer Res., 2:199–202.
  • Ueda, H., Takenawa, T., Millan, J.C., Gesell, M.S., and Brandes, D. (1980). The effects of retinoids on proliferative capacities and macromolecular synthesis in human breast cancer MCF-7 cells. Cancer, 46:2203–2209.
  • Uyeki, E.M. and Llacer, V. (1969). Effect of antibiotics on antibody-forming cells in vitro. Biochem. Pharmacol., 18:948–951.
  • Vaudaux, P., Kiefer, B., Forni, M., Joris, I., Majno, G., and Waldvogel, F.A. (1984). Doxorubicin impairs phago- cytic function and induces alterations in human neu- trophils. Cancer, 54:400–410.
  • Vincent, G.P. and Sepinwall, J. (1992). AF102B, a novel M1 agonist, enhanced spatial learning in C57BL/10 mice with a long duration of actions. Brain Res., 597:264– 268.
  • Waite, J.J. and Thal, L.J. (1995). The behavioral effects of heptylphysostigmine on rats lesioned in the nucleus basalis. Neurosci. Res., 21:251–259.
  • Wang, C. and Kurzer, M.S. (1997). Phytoestrogen concen- tration determines effects on DNA synthesis in human breast cancer cells. Nutr. Cancer, 28:236–247.
  • Wang, T.T.Y, Sathyamoorthy, N., and Phang, J.M. (1996). Molecular effects of genistein on estrogen receptor mediated pathways. Carcinogenesis, 17:271–275.
  • Witvrouw, M. and De Clercq, E. (1997). Sulfated polysac- charides extracted from sea algae as potential antiviral drugs. Gen. Pharmacol., 29:497–511.
  • Wu, F. Y-H. and Le Pecq, J-B. (1983). Mechanistic studies of a novel antitumor drug, -,3,5–triglycidyl-s- triazinetrione: antitumor and cytotoxic effects. Mol. Pharmcol., 23:182–189.
  • Xia, Z. and Storm, D.R. (1997). Calmodulin-regulated adenylyl cyclases and neuromodulation. Curr. Opin. Neurobiol., 7:391–396.
  • Xu, S. and Thomas, M.L. (1995). Biphasic actions of estro- gen on colon cancer cell growth: Possible mediation by high- and low-affinity estrogen binding sites. En- docrine, 3:661–665.
  • Zaman, G.J.R., Flens, M.J., van Leusden, M.R., de Haas, M., Mulder, H.S., Lankelma, J., Pinedo, H.M., Scheper, R.J., Baas, F., Broxterman, H.J., and Borst, P. (1994). The human multidrug resistance-associated protein MRP is a plasma membrane drug-efflux pump. Proc. Natl. Acad. Sci. U.S.A., 91:8822–8826.
  • Zappacosta, A.R. (1980). Reversal of baldness in a patient receiving Minoxidil for hypertension. N. Engl. J. Med., 303:1480–1481.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.